Skip to main content

Published locations for Efficacy, Safety, and Tolerability of Halobetasol Propionate 0.01%–Tazarotene 0.045% Lotion for Moderate to Severe Plaque Psoriasis in the Hispanic Population: Post Hoc Analysis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Efficacy, Safety, and Tolerability of Halobetasol Propionate 0.01%–Tazarotene 0.045% Lotion for Moderate to Severe Plaque Psoriasis in the Hispanic Population: Post Hoc Analysis

User login

  • Reset your password
  • /content/efficacy-safety-and-tolerability-halobetasol-propionate-001-tazarotene-0045-lotion-moderate
  • /cutis/article/218469/psoriasis/efficacy-safety-and-tolerability-halobetasol-propionate-001
  • /dermatology/article/218469/psoriasis/efficacy-safety-and-tolerability-halobetasol-propionate-001